food and drug administration fda

News

Sarepta Therapeutics, FDA and Gene

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators.

U.S. News & World Report · 19h

Children's Hospital LA Pauses Use of Sarepta Gene Therapy for All Patients

Children's Hospital Los Angeles, citing recent U.S. Food and Drug Administration actions, on Monday said it has paused usage of Sarepta Therapeutics' gene therapy Elevidys in all patients with muscular dystrophy.

MarketWatch · 6h

Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

Sarepta Therapeutics shares traded lower in premarket trade on Tuesday, as the drugmaker relented to a Food and Drug Administration request to halt the shipments of a gene therapy.

Power Stick deodorant, FDA

AOL · 2h

The FDA and Power Stick recalled thousands of deodorant cases because manufacturing practices did not comply with FDA standards. Here are the affected products.

TODAY on MSN · 22h

The FDA just recalled 67,000 cases of deodorant — here’s what you need to know

But one thing we’re confident about is that nobody wants to use a deodorant that has been recalled, which is why we are sharing this news: The Food and Drug Administration has issued a recall on 67,000 cases of Power Stick antiperspirant deodorant.

USA TODAY on MSN · 1d

More than 67,000 cases of popular Power Stick deodorant recalled

More than 67,000 cases of Power Stick deodorants were recalled for deviating from Food and Drug Administration standards.

FDA Announces Tuna Salad Recall in 7 States Due To Potential Listeria Contamination

The first recall affects tuna salad and ready-to-eat foods containing tuna salad sold at Jewel-Osco (which is owned by ...

The Hill on MSN7h

FDA commissioner stirs debate over hormone therapy for menopause

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

5hon MSN

Replimune says FDA rejected its lead drug for skin cancer

Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response ...

3hon MSN

FDA Issues Risk Warning for Bread Recall Update

The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...

20hon MSN

FDA names former pharmaceutical company executive to oversee US drug program

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

1don MSN

FDA appoints biotech executive as top drug regulator under RFK Jr.

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

1don MSN

Biotech exec George Tidmarsh picked as FDA's chief drug regulator

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

1don MSN

FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

1don MSN

FDA taps biotech industry veteran as RFK Jr.'s top drug regulator

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...

Health and Me on MSN2d

"Obsolete And Unnecessary": FDA Set To Revoke 52 Nutrition And Labeling Rules

The FDA plans to revoke 52 outdated nutrition and labeling regulations to streamline food industry standards, citing them as ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results